From: Early visual alterations in individuals at-risk of Alzheimer’s disease: a multidisciplinary approach
FH − | FH + | FH − 40-60ɛ4− | FH + 40-60ɛ4+ | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
n | rho | p | n | rho | p | n | rho | p | n | rho | p | |
VA | 32 | 0.033 | 0.571 | 94 | − 0.180 | *0.041 | 14 | 0.066 | 0.588 | 26 | − 0.408 | *0.019 |
CS-3 | 30 | − 0.021 | 0.456 | 90 | − 0.028 | 0.398 | 14 | − 0.472 | *0.044 | 26 | − 0.204 | 0.159 |
CS-6 | 30 | − 0.026 | 0.470 | 90 | − 0.008 | 0.470 | 14 | 0.078 | 0.604 | 26 | − 0.066 | 0.375 |
CS-12 | 30 | 0.247 | 0.906 | 90 | 0.084 | 0.785 | 14 | 0.061 | 0.582 | 26 | − 0.132 | 0.260 |
CS-18 | 30 | 0.085 | 0.672 | 90 | − 0.007 | 0.473 | 14 | − 0.194 | 0.253 | 26 | 0.050 | 0.596 |
IPL-N1 | 13 | 0.104 | 0.735 | 20 | − 0.029 | 0.903 | ||||||
IPL-N2 | 13 | 0.048 | 0.877 | 20 | − 0.062 | 0.796 | ||||||
IPL-S1 | 13 | − 0.184 | 0.548 | 20 | 0.063 | 0.791 | ||||||
IPL-I1 | 13 | − 0.096 | 0.754 | 20 | − 0.182 | 0.443 | ||||||
IPL-I2 | 13 | − 0.044 | 0.886 | 20 | − 0.475 | *0.034 | ||||||
INL-I2 | 13 | − 0.152 | 0.621 | 19 | − 0.370 | 0.119 |